covid
Endocrinología y Nutrición (English Edition) Efficacy and safety of empagliflozin in combination with other oral hypoglycemic...
Journal Information

Statistics

Follow this link to access the full text of the article

Original article
Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Eficacia y seguridad de empagliflozina en combinación con otros hipoglucemiantes orales en pacientes con diabetes mellitus tipo 2
Irene Romeraa,
Corresponding author
romerai@lilly.com

Corresponding author.
, Francisco Javier Ampudia-Blascob, Antonio Pérezc, Bernat Ariñod, Egon Pfarre, Sanja Giljanovic Kisf, Ebrahim Naderalig,h
a Eli Lilly and Company España, Alcobendas, Madrid, Spain
b Hospital Clínico Universitario de Valencia, Valencia, Spain
c Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
d Boehringer Ingelheim Pharma GmbH & Co., España, Sant Cugat del Vallès, Barcelona, Spain
e Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim am Rhein, Germany
f Eli Lilly (Suisse) SA Representative Office, Croatia, Zagreb, Croatia
g Eli Lilly and Company, UK, Basingstoke, United Kingdom
h Faculty of Science, Liverpool Hope University, Liverpool, United Kingdom
Read
19206
Times
was read the article
2361
Total PDF
16845
Total HTML
Share statistics
Article information
ISSN: 21735093
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 12 223 7 230
2025 11 972 90 1062
2025 10 476 35 511
2025 9 402 51 453
2025 8 456 26 482
2025 7 403 35 438
2025 6 375 29 404
2025 5 427 16 443
2025 4 360 12 372
2025 3 393 31 424
2025 2 315 22 337
2025 1 348 18 366
2024 12 198 14 212
2024 11 172 15 187
2024 10 191 22 213
2024 9 293 33 326
2024 8 225 21 246
2024 7 242 24 266
2024 6 202 17 219
2024 5 229 13 242
2024 4 202 25 227
2024 3 291 29 320
2024 2 308 14 322
2024 1 307 24 331
2023 12 253 26 279
2023 11 291 27 318
2023 10 358 27 385
2023 9 303 24 327
2023 8 316 12 328
2023 7 199 17 216
2023 6 227 26 253
2023 5 187 32 219
2023 4 165 22 187
2023 3 156 31 187
2023 2 136 15 151
2023 1 108 19 127
2022 12 200 30 230
2022 11 160 26 186
2022 10 138 18 156
2022 9 169 23 192
2022 8 177 34 211
2022 7 139 17 156
2022 6 160 33 193
2022 5 113 21 134
2022 4 133 29 162
2022 3 160 44 204
2022 2 130 19 149
2022 1 160 22 182
2021 12 123 21 144
2021 11 120 33 153
2021 10 118 40 158
2021 9 105 29 134
2021 8 92 20 112
2021 7 65 24 89
2021 6 91 17 108
2021 5 111 25 136
2021 4 264 111 375
2021 3 181 37 218
2021 2 120 28 148
2021 1 139 38 177
2020 12 132 30 162
2020 11 115 18 133
2020 10 79 15 94
2020 9 82 33 115
2020 8 98 23 121
2020 7 101 21 122
2020 6 72 16 88
2020 5 95 19 114
2020 4 76 31 107
2020 3 75 23 98
2020 2 94 25 119
2020 1 112 14 126
2019 12 149 28 177
2019 11 65 14 79
2019 10 103 21 124
2019 9 102 23 125
2019 8 71 20 91
2019 7 73 22 95
2019 6 74 60 134
2019 5 162 47 209
2019 4 63 9 72
2019 3 29 15 44
2019 2 35 18 53
2019 1 22 8 30
2018 12 15 4 19
2018 11 24 11 35
2018 10 14 8 22
2018 9 55 24 79
2018 8 45 8 53
2018 7 32 10 42
2018 6 49 12 61
2018 5 46 17 63
2018 4 35 6 41
2018 3 36 7 43
2018 2 40 8 48
2018 1 46 7 53
2017 12 54 9 63
2017 11 50 9 59
2017 10 37 8 45
2017 9 34 8 42
2017 8 38 4 42
2017 7 22 3 25
2017 6 14 5 19
2017 5 2 0 2
2016 12 1 0 1
Show all

Follow this link to access the full text of the article